Background: Upper Respiratory Infections are the most common diseases in childhood. It is possible to get even with no risk factors; although, if there are more factors, the higher it is the probability of illness. Methods: It was carried out an analytic study of cases and controls to identify risk factors associated with Recurrent Upper Respiratory Infections (RURI) in children under 5 years old from Habana Vieja municipality between January and June of the 2008, 40 children with RURI were studied selected by convenience sampling and 40 controls. Surveys were relatives. The group of cases was compared with the group control and then it was analyzed if the exhibition factor was associated to the RURI by means of the test of square chi, for that which was considered as significant a P ,0.05 in which case the test of odds ratio was applied (OR) to determine if really the factor or characteristic is or not of risk. Results: The most common was RURI was Adenoiditis with 18 cases (45%). All the cases had personal and family history of allergy, compared with 37.5% and 62,5% respectively in controls; (OR ¼ 25.4 P ¼ 0.0001 and OR ¼ 16,3 P ¼ 0.001). The adequate breastfeeding was more frequent in controls (OR ¼ 2.5 P ¼ 0.048). 70% of the cases were exposed to the smoke of the tobacco, and controls only 25% (OR ¼ 8.2). 92.5% of the homes of the cases and 70% of the controls had animals, especially dogs. The cold (92.5%), temperature changes (80%) and humidity (80%) were considered environmental risk factors in this study (OR ¼ 14.5 P ,0.001; OR ¼ 16.5 P , 0.001, OR ¼ 13.2 P ,0.002). Conclusions: Risk factors affecting the RURI are: personal and family history of allergy, inadequate breastfeeding, exposure to the smoke of tobacco and the presence of domestic animals, cold, changing weather and humidity.
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Biserka Jovkovska Kaeva, MD, PhD, and Zoran Arsovski, MD, MSc. Outpatient Department, Clinic of Pulmonology and Allergy, Skopje, Macedonia; Allergy and Clinical Immunology, Clinic of Pulmonology and Allergy, Skopje, Macedonia. Background: Exposure to asbestos can cause several different types of pleural disease: first diffuse malignant mezothelioma, plural plaques or calcification, loculated pleural abnormality called "rounded atelectasis" and benign pleural effusions (PE). Objective: To determine the frequency of various pleural diseases related to asbestos exposure. Methods: A retrospective analysis of 6 cases of PE related to the occupational asbestos exposure (AE) was made, after exclusion of other possible causes of PE. They were evaluated in the period of 7 years. Results: All cases were male and almost all were more than 60 years old. All cases had more then 30 years from the first occupational AE (5 in building construction and sixt in mine). All of them reported pleuritic chest pain, or feeling heavy in their chest. The chest radiographs showed small to moderatesized PE, which was bilateral by tree patients (pts) by the others with pleural califications in one of them. One of the pts had 3 episodes of PE and evidence of parenhimal asbestosis. PE was serous exudate and serosanguineous in 2 pts, with polymorphonuclear leucocytes, mononuclear cells and eosinophils (EO). We have evaluated the number of EO in the pleural fluid (PF), from the smear of PF colored by May-Grunwald-Giemsa. The PF differential WBC consisted predominately EO and mononuclear cells. At 4 pts more than 30% EO were found in the PF and 21% and 17% in other 2 pts respectively. During the follow up period of 3 years no other cause of PE has been found and there has been no evidence of mesothelioma in all the pts. Conclusions: Exposure to asbestos can cause PE with predominant presence of Eo cells. Background: Transfer factor was first described in 1955 and constitutes a Dialyzable Leukocyte Extract. It has been widely used in several infectious diseases and malignancies with satisfactory results. Although not yet fully clarified, among the mechanisms of action the most accepted is the enhancement of the cellular immunity. Methods: We tested transfer factor in a 1 year old and 3 months patient diagnosed with Ganglionar Tuberculosis. 1 week after the administrarion of the Bacillus Calmette-Guérin vaccination, the present developed fever, cervical, submandibular, supraclavicular, inguinal and axillary lymphadenopathy. Later on the patient devoloped cutaneous clinical manifestations of tuberculosis such as scrofuloderma, fistulas, hypertrophic scars and ultimately, queloids. The patient had previously undergone short-term strictly supervised treatment for tuberculosis with very poor results. When the treatment was first administered, the patient had the following data: Total White Blood Count 12.9 Lymphocytes: 29% (12-46) CD3: 26.3% (59-90) T helper Cells (CD3/CD4) 21.6% (42-58) Cytotoxic T cells (CD3/CD8) 5.1% (17-33) Natural Killer Cells (CD56) 2.1% (3-7) B cells (CD19) 67.6 % (0-10). Results: At the end of the treatment, the patient s immune system was enhanced in terms of cell count and improval of skin manifestations. Total White Blood Count 6.5 Lymphocytes: 51.3% CD3: 48.5% T helper cells (CD3/CD4) 31.2% Cytotoxic T Cells (CD3/CD8) 14.6% Natural Killer cells (CD56) 12.2% B cells (CD19) 985%. Cicatrization process was improved, with involution of skin lesions os scrofuloderma and fistulas. Lymphadenopathy was no longer encountered. We have followed the patient for a year and half and no relapses have been encountered. Conclusions: We consider Transfer Factor a valuable option as adyuvant therapy in cases of ganglionar and cutaneous tuberculosis refractory to conventional treatments. To our knowledge, this is the first report of a case of the disease treated satisfactorily with transfer factor.
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